主要文件

查看所有文档

H0252

羟基磷灰石

Name: 羟基磷灰石
Brand: SIAL

Type I, buffered aqueous suspension

别名:

牛骨粉, 碱式磷酸钙, 羟磷灰石

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:

3Ca₃(PO₄)₂ · Ca(OH)₂

化学文摘社编号:

1306-06-5

分子量:

502.31

NACRES:

NA.25

PubChem Substance ID:

24895395

UNSPSC Code:

12161700

EC Number:

215-145-7

MDL number:

MFCD00010904

Form:

buffered aqueous suspension

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

type

Type I

Quality Level

200

form

buffered aqueous suspension

storage temp.

2-8°C

SMILES string

[Ca++].[Ca++].[Ca++].[Ca++].O[Ca+].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O

InChI

1S/5Ca.3H3O4P.H2O/c;;;;;3*1-5(2,3)4;/h;;;;;3*(H3,1,2,3,4);1H2/q5*+2;;;;/p-10

InChI key

XYJRXVWERLGGKC-UHFFFAOYSA-D

说明

Application

用于纯化蛋白质和核酸。

Packaging

根据干重确定包装尺寸

Physical form

悬浮于 0.001M 磷酸盐缓冲液中，pH 为 6.8；固体含量约为 25%

Still not finding the right product?

Explore all of our products under 羟基磷灰石

存储类别

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Lower reoperation rate for cemented hemiarthroplasty than for uncemented hemiarthroplasty and internal fixation following femoral neck fracture: 12- to 19-year follow-up of patients aged 75 years or more.

Bjarke Viberg et al.

Acta orthopaedica, 84(3), 254-259 (2013-04-19)

Elderly patients with displaced femoral neck fractures are commonly treated with a hemiarthroplasty (HA), but little is known about the long-term failure of this treatment. We compared reoperation rates for patients aged at least 75 years with displaced femoral neck

Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques.

Sophie E P New et al.

Circulation research, 113(1), 72-77 (2013-04-26)

We previously showed that early calcification of atherosclerotic plaques associates with macrophage accumulation. Chronic renal disease and mineral imbalance accelerate calcification and the subsequent release of matrix vesicles (MVs), precursors of microcalcification. We tested the hypothesis that macrophage-derived MVs contribute

Targeting angiogenesis-dependent calcified neoplasms using combined polymer therapeutics.

Ehud Segal et al.

PloS one, 4(4), e5233-e5233 (2009-04-22)

There is an immense clinical need for novel therapeutics for the treatment of angiogenesis-dependent calcified neoplasms such as osteosarcomas and bone metastases. We developed a new therapeutic strategy to target bone metastases and calcified neoplasms using combined polymer-bound angiogenesis inhibitors.

查看所有相关文献

全球贸易项目编号

货号	GTIN
H0252-25G	04061832862231
H0252-250G	04061832401621
H0252-65G	04061832401638